Aligos Therapeutics, Inc. (ALGS) NASDAQ

6.80

-0.32(-4.49%)

Updated at February 20 04:00PM

Currency In USD

Valuation

Market Cap249.58M
Enterprise Value220.96M
P/E Ratio-0.82
PEG Ratio-3.41
Price/Sales Ratio15.81
Price/Book Ratio0.98
Enterprise/Revenue2.25
Enterprise/EBITDA-0.07

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-32.68
Operating Margin-32.78

Management Effectiveness

Return On Assets-0.79
Return On Equity-1.32

Income Statement

Revenue3.95M
Revenue/Share0.26
Gross Profit3.95M
EBITDA-86.53M
Net Income-131.21M
Diluted EPS-20.94

Balance Sheet

Total Cash99.1M
Total Cash/Share9.56
Total Debt6.07M
Total Debt/Equity0.08
Current Ratio4.7
Book Value Per Share6.93

Price History

52-Week Change-63.5
52-Week High24.33
52-Week Low3.76
Moving Average 50 Days9.14
Moving Average 200 Days8.49

Statistics

Average Volume73,623
Shares Outstanding6.15M
% Held by Institutions27.11

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:25
Last Split DateAugust 19, 2024